The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Alpha Radionuclide Market Research Report 2025
Synopsis
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Medical Alpha Radionuclide market was valued at US$ 3281 million in 2023 and is anticipated to reach US$ 8028 million by 2030, witnessing a CAGR of 14.6% during the forecast period 2024-2030.
North American market for Medical Alpha Radionuclide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Alpha Radionuclide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Alpha Radionuclide include ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Alpha Radionuclide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Alpha Radionuclide.
The Medical Alpha Radionuclide market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Alpha Radionuclide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Alpha Radionuclide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ORNL
Tri-Lab
SSC RF-IPPE
JRC Karlsruhe
TerraPower
TRIUMF
Eckert&Ziegler
Ionetix
Orano Med
National Nuclear Laboratory
NorthStar
by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Alpha Radionuclide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Medical Alpha Radionuclide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Medical Alpha Radionuclide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Medical Alpha Radionuclide market was valued at US$ 3281 million in 2023 and is anticipated to reach US$ 8028 million by 2030, witnessing a CAGR of 14.6% during the forecast period 2024-2030.
North American market for Medical Alpha Radionuclide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Alpha Radionuclide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Alpha Radionuclide include ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Alpha Radionuclide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Alpha Radionuclide.
The Medical Alpha Radionuclide market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Alpha Radionuclide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Alpha Radionuclide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ORNL
Tri-Lab
SSC RF-IPPE
JRC Karlsruhe
TerraPower
TRIUMF
Eckert&Ziegler
Ionetix
Orano Med
National Nuclear Laboratory
NorthStar
by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Alpha Radionuclide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Medical Alpha Radionuclide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Medical Alpha Radionuclide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Medical Alpha Radionuclide Market Overview
1.1 Product Definition
1.2 Medical Alpha Radionuclide by Type
1.2.1 Global Medical Alpha Radionuclide Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Actinium-225
1.2.3 Astatine-211
1.2.4 Lead-212
1.2.5 Bismuth-213
1.2.6 Others
1.3 Medical Alpha Radionuclide by Application
1.3.1 Global Medical Alpha Radionuclide Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Immunotherapy
1.3.3 Peritoneal Carcinomas
1.3.4 Bone Metastases
1.3.5 Leukaemia
1.3.6 Melanomas
1.3.7 Solid Tumours
1.4 Global Market Growth Prospects
1.4.1 Global Medical Alpha Radionuclide Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Medical Alpha Radionuclide Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Medical Alpha Radionuclide Production Estimates and Forecasts (2019-2030)
1.4.4 Global Medical Alpha Radionuclide Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Medical Alpha Radionuclide Production Market Share by Manufacturers (2019-2024)
2.2 Global Medical Alpha Radionuclide Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Medical Alpha Radionuclide, Industry Ranking, 2022 VS 2023
2.4 Global Medical Alpha Radionuclide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Alpha Radionuclide Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Medical Alpha Radionuclide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medical Alpha Radionuclide, Product Offered and Application
2.8 Global Key Manufacturers of Medical Alpha Radionuclide, Date of Enter into This Industry
2.9 Medical Alpha Radionuclide Market Competitive Situation and Trends
2.9.1 Medical Alpha Radionuclide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Medical Alpha Radionuclide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medical Alpha Radionuclide Production by Region
3.1 Global Medical Alpha Radionuclide Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Medical Alpha Radionuclide Production Value by Region (2019-2030)
3.2.1 Global Medical Alpha Radionuclide Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Medical Alpha Radionuclide by Region (2025-2030)
3.3 Global Medical Alpha Radionuclide Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Medical Alpha Radionuclide Production by Region (2019-2030)
3.4.1 Global Medical Alpha Radionuclide Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Medical Alpha Radionuclide by Region (2025-2030)
3.5 Global Medical Alpha Radionuclide Market Price Analysis by Region (2019-2024)
3.6 Global Medical Alpha Radionuclide Production and Value, Year-over-Year Growth
3.6.1 North America Medical Alpha Radionuclide Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Medical Alpha Radionuclide Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Medical Alpha Radionuclide Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Medical Alpha Radionuclide Production Value Estimates and Forecasts (2019-2030)
4 Medical Alpha Radionuclide Consumption by Region
4.1 Global Medical Alpha Radionuclide Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Medical Alpha Radionuclide Consumption by Region (2019-2030)
4.2.1 Global Medical Alpha Radionuclide Consumption by Region (2019-2030)
4.2.2 Global Medical Alpha Radionuclide Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Medical Alpha Radionuclide Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Medical Alpha Radionuclide Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Medical Alpha Radionuclide Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Medical Alpha Radionuclide Production by Type (2019-2030)
5.1.1 Global Medical Alpha Radionuclide Production by Type (2019-2024)
5.1.2 Global Medical Alpha Radionuclide Production by Type (2025-2030)
5.1.3 Global Medical Alpha Radionuclide Production Market Share by Type (2019-2030)
5.2 Global Medical Alpha Radionuclide Production Value by Type (2019-2030)
5.2.1 Global Medical Alpha Radionuclide Production Value by Type (2019-2024)
5.2.2 Global Medical Alpha Radionuclide Production Value by Type (2025-2030)
5.2.3 Global Medical Alpha Radionuclide Production Value Market Share by Type (2019-2030)
5.3 Global Medical Alpha Radionuclide Price by Type (2019-2030)
6 Segment by Application
6.1 Global Medical Alpha Radionuclide Production by Application (2019-2030)
6.1.1 Global Medical Alpha Radionuclide Production by Application (2019-2024)
6.1.2 Global Medical Alpha Radionuclide Production by Application (2025-2030)
6.1.3 Global Medical Alpha Radionuclide Production Market Share by Application (2019-2030)
6.2 Global Medical Alpha Radionuclide Production Value by Application (2019-2030)
6.2.1 Global Medical Alpha Radionuclide Production Value by Application (2019-2024)
6.2.2 Global Medical Alpha Radionuclide Production Value by Application (2025-2030)
6.2.3 Global Medical Alpha Radionuclide Production Value Market Share by Application (2019-2030)
6.3 Global Medical Alpha Radionuclide Price by Application (2019-2030)
7 Key Companies Profiled
7.1 ORNL
7.1.1 ORNL Medical Alpha Radionuclide Company Information
7.1.2 ORNL Medical Alpha Radionuclide Product Portfolio
7.1.3 ORNL Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.1.4 ORNL Main Business and Markets Served
7.1.5 ORNL Recent Developments/Updates
7.2 Tri-Lab
7.2.1 Tri-Lab Medical Alpha Radionuclide Company Information
7.2.2 Tri-Lab Medical Alpha Radionuclide Product Portfolio
7.2.3 Tri-Lab Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Tri-Lab Main Business and Markets Served
7.2.5 Tri-Lab Recent Developments/Updates
7.3 SSC RF-IPPE
7.3.1 SSC RF-IPPE Medical Alpha Radionuclide Company Information
7.3.2 SSC RF-IPPE Medical Alpha Radionuclide Product Portfolio
7.3.3 SSC RF-IPPE Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.3.4 SSC RF-IPPE Main Business and Markets Served
7.3.5 SSC RF-IPPE Recent Developments/Updates
7.4 JRC Karlsruhe
7.4.1 JRC Karlsruhe Medical Alpha Radionuclide Company Information
7.4.2 JRC Karlsruhe Medical Alpha Radionuclide Product Portfolio
7.4.3 JRC Karlsruhe Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.4.4 JRC Karlsruhe Main Business and Markets Served
7.4.5 JRC Karlsruhe Recent Developments/Updates
7.5 TerraPower
7.5.1 TerraPower Medical Alpha Radionuclide Company Information
7.5.2 TerraPower Medical Alpha Radionuclide Product Portfolio
7.5.3 TerraPower Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.5.4 TerraPower Main Business and Markets Served
7.5.5 TerraPower Recent Developments/Updates
7.6 TRIUMF
7.6.1 TRIUMF Medical Alpha Radionuclide Company Information
7.6.2 TRIUMF Medical Alpha Radionuclide Product Portfolio
7.6.3 TRIUMF Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.6.4 TRIUMF Main Business and Markets Served
7.6.5 TRIUMF Recent Developments/Updates
7.7 Eckert&Ziegler
7.7.1 Eckert&Ziegler Medical Alpha Radionuclide Company Information
7.7.2 Eckert&Ziegler Medical Alpha Radionuclide Product Portfolio
7.7.3 Eckert&Ziegler Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Eckert&Ziegler Main Business and Markets Served
7.7.5 Eckert&Ziegler Recent Developments/Updates
7.8 Ionetix
7.8.1 Ionetix Medical Alpha Radionuclide Company Information
7.8.2 Ionetix Medical Alpha Radionuclide Product Portfolio
7.8.3 Ionetix Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Ionetix Main Business and Markets Served
7.8.5 Ionetix Recent Developments/Updates
7.9 Orano Med
7.9.1 Orano Med Medical Alpha Radionuclide Company Information
7.9.2 Orano Med Medical Alpha Radionuclide Product Portfolio
7.9.3 Orano Med Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Orano Med Main Business and Markets Served
7.9.5 Orano Med Recent Developments/Updates
7.10 National Nuclear Laboratory
7.10.1 National Nuclear Laboratory Medical Alpha Radionuclide Company Information
7.10.2 National Nuclear Laboratory Medical Alpha Radionuclide Product Portfolio
7.10.3 National Nuclear Laboratory Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.10.4 National Nuclear Laboratory Main Business and Markets Served
7.10.5 National Nuclear Laboratory Recent Developments/Updates
7.11 NorthStar
7.11.1 NorthStar Medical Alpha Radionuclide Company Information
7.11.2 NorthStar Medical Alpha Radionuclide Product Portfolio
7.11.3 NorthStar Medical Alpha Radionuclide Production, Value, Price and Gross Margin (2019-2024)
7.11.4 NorthStar Main Business and Markets Served
7.11.5 NorthStar Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medical Alpha Radionuclide Industry Chain Analysis
8.2 Medical Alpha Radionuclide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medical Alpha Radionuclide Production Mode & Process
8.4 Medical Alpha Radionuclide Sales and Marketing
8.4.1 Medical Alpha Radionuclide Sales Channels
8.4.2 Medical Alpha Radionuclide Distributors
8.5 Medical Alpha Radionuclide Customers
9 Medical Alpha Radionuclide Market Dynamics
9.1 Medical Alpha Radionuclide Industry Trends
9.2 Medical Alpha Radionuclide Market Drivers
9.3 Medical Alpha Radionuclide Market Challenges
9.4 Medical Alpha Radionuclide Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Medical Alpha Radionuclide Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Medical Alpha Radionuclide Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Medical Alpha Radionuclide Production Capacity (kg) by Manufacturers in 2023
Table 4. Global Medical Alpha Radionuclide Production by Manufacturers (2019-2024) & (kg)
Table 5. Global Medical Alpha Radionuclide Production Market Share by Manufacturers (2019-2024)
Table 6. Global Medical Alpha Radionuclide Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Medical Alpha Radionuclide Production Value Share by Manufacturers (2019-2024)
Table 8. Global Key Players of Medical Alpha Radionuclide, Industry Ranking, 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Medical Alpha Radionuclide as of 2023)
Table 10. Global Market Medical Alpha Radionuclide Average Price by Manufacturers (US$/g) & (2019-2024)
Table 11. Global Key Manufacturers of Medical Alpha Radionuclide, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Medical Alpha Radionuclide, Product Offered and Application
Table 13. Global Key Manufacturers of Medical Alpha Radionuclide, Date of Enter into This Industry
Table 14. Global Medical Alpha Radionuclide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Alpha Radionuclide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Medical Alpha Radionuclide Production Value (US$ Million) by Region (2019-2024)
Table 18. Global Medical Alpha Radionuclide Production Value Market Share by Region (2019-2024)
Table 19. Global Medical Alpha Radionuclide Production Value (US$ Million) Forecast by Region (2025-2030)
Table 20. Global Medical Alpha Radionuclide Production Value Market Share Forecast by Region (2025-2030)
Table 21. Global Medical Alpha Radionuclide Production Comparison by Region: 2019 VS 2023 VS 2030 (kg)
Table 22. Global Medical Alpha Radionuclide Production (kg) by Region (2019-2024)
Table 23. Global Medical Alpha Radionuclide Production Market Share by Region (2019-2024)
Table 24. Global Medical Alpha Radionuclide Production (kg) Forecast by Region (2025-2030)
Table 25. Global Medical Alpha Radionuclide Production Market Share Forecast by Region (2025-2030)
Table 26. Global Medical Alpha Radionuclide Market Average Price (US$/g) by Region (2019-2024)
Table 27. Global Medical Alpha Radionuclide Market Average Price (US$/g) by Region (2025-2030)
Table 28. Global Medical Alpha Radionuclide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (kg)
Table 29. Global Medical Alpha Radionuclide Consumption by Region (2019-2024) & (kg)
Table 30. Global Medical Alpha Radionuclide Consumption Market Share by Region (2019-2024)
Table 31. Global Medical Alpha Radionuclide Forecasted Consumption by Region (2025-2030) & (kg)
Table 32. Global Medical Alpha Radionuclide Forecasted Consumption Market Share by Region (2019-2024)
Table 33. North America Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (kg)
Table 34. North America Medical Alpha Radionuclide Consumption by Country (2019-2024) & (kg)
Table 35. North America Medical Alpha Radionuclide Consumption by Country (2025-2030) & (kg)
Table 36. Europe Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (kg)
Table 37. Europe Medical Alpha Radionuclide Consumption by Country (2019-2024) & (kg)
Table 38. Europe Medical Alpha Radionuclide Consumption by Country (2025-2030) & (kg)
Table 39. Asia Pacific Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (kg)
Table 40. Asia Pacific Medical Alpha Radionuclide Consumption by Region (2019-2024) & (kg)
Table 41. Asia Pacific Medical Alpha Radionuclide Consumption by Region (2025-2030) & (kg)
Table 42. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (kg)
Table 43. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (2019-2024) & (kg)
Table 44. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (2025-2030) & (kg)
Table 45. Global Medical Alpha Radionuclide Production (kg) by Type (2019-2024)
Table 46. Global Medical Alpha Radionuclide Production (kg) by Type (2025-2030)
Table 47. Global Medical Alpha Radionuclide Production Market Share by Type (2019-2024)
Table 48. Global Medical Alpha Radionuclide Production Market Share by Type (2025-2030)
Table 49. Global Medical Alpha Radionuclide Production Value (US$ Million) by Type (2019-2024)
Table 50. Global Medical Alpha Radionuclide Production Value (US$ Million) by Type (2025-2030)
Table 51. Global Medical Alpha Radionuclide Production Value Market Share by Type (2019-2024)
Table 52. Global Medical Alpha Radionuclide Production Value Market Share by Type (2025-2030)
Table 53. Global Medical Alpha Radionuclide Price (US$/g) by Type (2019-2024)
Table 54. Global Medical Alpha Radionuclide Price (US$/g) by Type (2025-2030)
Table 55. Global Medical Alpha Radionuclide Production (kg) by Application (2019-2024)
Table 56. Global Medical Alpha Radionuclide Production (kg) by Application (2025-2030)
Table 57. Global Medical Alpha Radionuclide Production Market Share by Application (2019-2024)
Table 58. Global Medical Alpha Radionuclide Production Market Share by Application (2025-2030)
Table 59. Global Medical Alpha Radionuclide Production Value (US$ Million) by Application (2019-2024)
Table 60. Global Medical Alpha Radionuclide Production Value (US$ Million) by Application (2025-2030)
Table 61. Global Medical Alpha Radionuclide Production Value Market Share by Application (2019-2024)
Table 62. Global Medical Alpha Radionuclide Production Value Market Share by Application (2025-2030)
Table 63. Global Medical Alpha Radionuclide Price (US$/g) by Application (2019-2024)
Table 64. Global Medical Alpha Radionuclide Price (US$/g) by Application (2025-2030)
Table 65. ORNL Medical Alpha Radionuclide Company Information
Table 66. ORNL Medical Alpha Radionuclide Specification and Application
Table 67. ORNL Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 68. ORNL Main Business and Markets Served
Table 69. ORNL Recent Developments/Updates
Table 70. Tri-Lab Medical Alpha Radionuclide Company Information
Table 71. Tri-Lab Medical Alpha Radionuclide Specification and Application
Table 72. Tri-Lab Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 73. Tri-Lab Main Business and Markets Served
Table 74. Tri-Lab Recent Developments/Updates
Table 75. SSC RF-IPPE Medical Alpha Radionuclide Company Information
Table 76. SSC RF-IPPE Medical Alpha Radionuclide Specification and Application
Table 77. SSC RF-IPPE Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 78. SSC RF-IPPE Main Business and Markets Served
Table 79. SSC RF-IPPE Recent Developments/Updates
Table 80. JRC Karlsruhe Medical Alpha Radionuclide Company Information
Table 81. JRC Karlsruhe Medical Alpha Radionuclide Specification and Application
Table 82. JRC Karlsruhe Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 83. JRC Karlsruhe Main Business and Markets Served
Table 84. JRC Karlsruhe Recent Developments/Updates
Table 85. TerraPower Medical Alpha Radionuclide Company Information
Table 86. TerraPower Medical Alpha Radionuclide Specification and Application
Table 87. TerraPower Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 88. TerraPower Main Business and Markets Served
Table 89. TerraPower Recent Developments/Updates
Table 90. TRIUMF Medical Alpha Radionuclide Company Information
Table 91. TRIUMF Medical Alpha Radionuclide Specification and Application
Table 92. TRIUMF Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 93. TRIUMF Main Business and Markets Served
Table 94. TRIUMF Recent Developments/Updates
Table 95. Eckert&Ziegler Medical Alpha Radionuclide Company Information
Table 96. Eckert&Ziegler Medical Alpha Radionuclide Specification and Application
Table 97. Eckert&Ziegler Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 98. Eckert&Ziegler Main Business and Markets Served
Table 99. Eckert&Ziegler Recent Developments/Updates
Table 100. Ionetix Medical Alpha Radionuclide Company Information
Table 101. Ionetix Medical Alpha Radionuclide Specification and Application
Table 102. Ionetix Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 103. Ionetix Main Business and Markets Served
Table 104. Ionetix Recent Developments/Updates
Table 105. Orano Med Medical Alpha Radionuclide Company Information
Table 106. Orano Med Medical Alpha Radionuclide Specification and Application
Table 107. Orano Med Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 108. Orano Med Main Business and Markets Served
Table 109. Orano Med Recent Developments/Updates
Table 110. National Nuclear Laboratory Medical Alpha Radionuclide Company Information
Table 111. National Nuclear Laboratory Medical Alpha Radionuclide Specification and Application
Table 112. National Nuclear Laboratory Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 113. National Nuclear Laboratory Main Business and Markets Served
Table 114. National Nuclear Laboratory Recent Developments/Updates
Table 115. NorthStar Medical Alpha Radionuclide Company Information
Table 116. NorthStar Medical Alpha Radionuclide Specification and Application
Table 117. NorthStar Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
Table 118. NorthStar Main Business and Markets Served
Table 119. NorthStar Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Medical Alpha Radionuclide Distributors List
Table 123. Medical Alpha Radionuclide Customers List
Table 124. Medical Alpha Radionuclide Market Trends
Table 125. Medical Alpha Radionuclide Market Drivers
Table 126. Medical Alpha Radionuclide Market Challenges
Table 127. Medical Alpha Radionuclide Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Alpha Radionuclide
Figure 2. Global Medical Alpha Radionuclide Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Medical Alpha Radionuclide Market Share by Type: 2023 VS 2030
Figure 4. Actinium-225 Product Picture
Figure 5. Astatine-211 Product Picture
Figure 6. Lead-212 Product Picture
Figure 7. Bismuth-213 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Medical Alpha Radionuclide Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global Medical Alpha Radionuclide Market Share by Application: 2023 VS 2030
Figure 11. Immunotherapy
Figure 12. Peritoneal Carcinomas
Figure 13. Bone Metastases
Figure 14. Leukaemia
Figure 15. Melanomas
Figure 16. Solid Tumours
Figure 17. Global Medical Alpha Radionuclide Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Medical Alpha Radionuclide Production Value (US$ Million) & (2019-2030)
Figure 19. Global Medical Alpha Radionuclide Production Capacity (kg) & (2019-2030)
Figure 20. Global Medical Alpha Radionuclide Production (kg) & (2019-2030)
Figure 21. Global Medical Alpha Radionuclide Average Price (US$/g) & (2019-2030)
Figure 22. Medical Alpha Radionuclide Report Years Considered
Figure 23. Medical Alpha Radionuclide Production Share by Manufacturers in 2023
Figure 24. Medical Alpha Radionuclide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. The Global 5 and 10 Largest Players: Market Share by Medical Alpha Radionuclide Revenue in 2023
Figure 26. Global Medical Alpha Radionuclide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 27. Global Medical Alpha Radionuclide Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Medical Alpha Radionuclide Production Comparison by Region: 2019 VS 2023 VS 2030 (kg)
Figure 29. Global Medical Alpha Radionuclide Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 31. Europe Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 32. China Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 33. Japan Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 34. Global Medical Alpha Radionuclide Consumption by Region: 2019 VS 2023 VS 2030 (kg)
Figure 35. Global Medical Alpha Radionuclide Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 36. North America Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 37. North America Medical Alpha Radionuclide Consumption Market Share by Country (2019-2030)
Figure 38. U.S. Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 39. Canada Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 40. Europe Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 41. Europe Medical Alpha Radionuclide Consumption Market Share by Country (2019-2030)
Figure 42. Germany Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 43. France Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 44. U.K. Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 45. Italy Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 46. Russia Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 47. Asia Pacific Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 48. Asia Pacific Medical Alpha Radionuclide Consumption Market Share by Region (2025-2030)
Figure 49. China Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 50. Japan Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 51. South Korea Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 52. China Taiwan Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 53. Southeast Asia Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 54. India Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 55. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 56. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Market Share by Country (2019-2030)
Figure 57. Mexico Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 58. Brazil Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 59. Turkey Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 60. GCC Countries Medical Alpha Radionuclide Consumption and Growth Rate (2019-2030) & (kg)
Figure 61. Global Production Market Share of Medical Alpha Radionuclide by Type (2019-2030)
Figure 62. Global Production Value Market Share of Medical Alpha Radionuclide by Type (2019-2030)
Figure 63. Global Medical Alpha Radionuclide Price (US$/g) by Type (2019-2030)
Figure 64. Global Production Market Share of Medical Alpha Radionuclide by Application (2019-2030)
Figure 65. Global Production Value Market Share of Medical Alpha Radionuclide by Application (2019-2030)
Figure 66. Global Medical Alpha Radionuclide Price (US$/g) by Application (2019-2030)
Figure 67. Medical Alpha Radionuclide Value Chain
Figure 68. Medical Alpha Radionuclide Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
